Brief: Wockhardt, Jemincare Partner For Respiratory Antibiotic Nafithromycin

Wockhardt

26/08/2021 04:53

Aug 26 (Reuters) - Wockhardt Ltd  WCKH.NS :
    * WOCKHARDT AND JEMINCARE PARTNER FOR NOVEL RESPIRATORY
ANTIBIOTIC
NAFITHROMYCIN
    * WOCKHARDT TO RECEIVE UPFRONT AND MILESTONE PAYMENTS, IN
ADDITION
TO ROYALTIES
    * JEMINCARE TO BE RESPONSIBLE FOR  EXCLUSIVE DEVELOPMENT,
COMMERCIALIZATION OF NAFITHROMYCIN IN SELECT MARKETS
    * WOCKHARDT WOULD SUPPLY PRODUCT TO JEMINCARE, RECEIVE
ROYALTIES
ON NET SALES
    * WOCKHARDT WOULD TRANSFER MANUFACTURING TECHNOLOGY TO
JEMINCARE
AT MUTUALLY AGREED TIME
    * CO TO CONTINUE TO DEVELOP NAFITHROMYCIN FOR OTHER MARKETS
INCLUDING INDIA

Source text for Eikon:  ID:nBSE7C8H8C 
Further company coverage:  WCKH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))